ELF Q4 Earnings Surpass Estimates, Net Sales Increase Y/Y

e.l.f. Beauty beat fourth-quarter fiscal 2026 estimates with adjusted EPS of $0.32 versus $0.29 consensus and net sales of $449.3 million versus $426 million expected, with revenue up 35.1% year over year. However, adjusted EPS fell 59% and adjusted EBITDA declined 27.7% to $58.8 million as SG&A rose sharply and tariffs weighed on margins. Management guided fiscal 2027 net sales of $1.835-$1.865 billion, implying 12%-14% growth, with adjusted EBITDA of $379-$385 million and gross margin around 71%.

Analysis

ELF’s print reinforces a key market misconception: this is no longer a pure “category disruptor” multiple story, but a more complex integration-and-margin trade. Rhode is now big enough to move the tape, but it also changes the earnings quality mix — if the acquired brand is driving most of the top-line beat while organic growth is barely positive, the market will increasingly value execution on synergy capture and distribution efficiency rather than just growth rate.

The bigger second-order issue is that tariffs are becoming a quasi-permanent input tax, not a temporary shock. Management’s guide implies they can offset part of that through pricing and mix, but the market should treat gross margin as capped unless the company either meaningfully de-risks sourcing or shifts more volume into higher-margin channels. That makes the next two quarters a margin credibility test: if marketing intensity stays elevated while growth normalizes, operating leverage can deteriorate quickly even with decent revenue.

Competitively, the pressure lands most on prestige-adjacent and value-beauty peers that lack ELF’s social/digital engine, but it also raises the bar for all small-cap beauty brands relying on acquisition-led growth. The balance sheet expansion matters because leverage is now high enough that any miss in integration, inventory, or tariff pass-through will be punished harder by the market. The stock’s recent drawdown already prices some of this in, but consensus likely still underestimates how little room there is for another EBITDA reset before the de-rating becomes structural.

Key Decisions for Investors

• Stay cautious on ELF into the next 1-2 quarters: the risk/reward favors waiting for evidence that Rhode synergies are translating into sustained organic growth and margin stabilization rather than chasing a headline beat.
• For tactical upside, consider a limited-risk call spread in ELF only after confirmation that gross margin holds near or above the low-70s while marketing spend normalizes; otherwise the downside from another EBITDA miss remains asymmetric.
• Relative value: short ELF vs long EL on a 3-6 month horizon if you want to express 'quality of earnings' dispersion; EL offers cleaner operating leverage and less balance-sheet complexity, while ELF still faces integration and tariff risk.
• Avoid pairing ELF with NUS/IPAR on fundamentals alone — the cleaner expression is ELF vs a more defensively run beauty name, because the key variable here is execution friction, not just end-demand.
• If ELF sells off further on any post-earnings margin commentary, use weakness to evaluate a tradeable bounce only with a hard stop: the stock can work on valuation, but not until guidance credibility improves.